首页> 美国卫生研究院文献>Molecular Vision >TECHNICAL BRIEF: Isolation of total DNA from postmortem human eye tissues and quality comparison between iris and retina
【2h】

TECHNICAL BRIEF: Isolation of total DNA from postmortem human eye tissues and quality comparison between iris and retina

机译:技术简介:死后人眼组织中总DNA的分离以及虹膜和视网膜之间的质量比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundRecent genomic technologies have propelled our understanding of the mechanisms underlying complex eye diseases such as age-related macular degeneration (AMD). Genotyping postmortem eye tissues for known single nucleotide polymorphisms (SNPs) associated with AMD may prove valuable, especially when combined with information obtained through other methods such as immunohistochemistry, western blot, enzyme-linked immunosorbent assay (ELISA), and proteomics. Initially intending to genotype postmortem eye tissues for AMD-related SNPs, our group became interested in isolating and comparing the quality of DNA from the iris and retina of postmortem donor eyes. Since there is no previously published protocol in the literature on this topic, we present a protocol suitable for isolating high-quality DNA from postmortem eye tissues for genomic studies.
机译:背景技术最近的基因组技术推动了我们对复杂的眼部疾病(例如与年龄有关的黄斑变性(AMD))的潜在机制的理解。对与AMD相关的已知单核苷酸多态性(SNP)进行死后眼组织基因分型可能被证明是有价值的,尤其是与通过其他方法(例如免疫组织化学,蛋白质印迹,酶联免疫吸附测定(ELISA)和蛋白质组学)获得的信息结合在一起时。最初打算对与AMD相关的SNP进行死后眼组织基因分型,我们小组开始对分离和比较死后供体眼睛虹膜和视网膜DNA的质量感兴趣。由于文献中没有关于此主题的先前发表的协议,因此我们提出了一种适用于从死后眼组织中分离高质量DNA进行基因组研究的协议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号